What is the recommended dosing regimen for Amiodarone (antiarrhythmic medication) drip in an adult patient with life-threatening arrhythmias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Drip Dosing for Life-Threatening Arrhythmias

For adult patients with life-threatening ventricular arrhythmias, administer amiodarone as a 150 mg IV bolus over 10 minutes, followed by 1 mg/min infusion for 6 hours, then 0.5 mg/min for the remaining 18 hours, with a maximum total dose of 2.2 g over 24 hours. 1, 2

Initial Loading Protocol

First 24 Hours:

  • Loading bolus: 150 mg IV over 10 minutes (can be repeated if VT recurs) 1, 3
  • First 6 hours: 1 mg/min continuous infusion (360 mg total) 1, 2, 3
  • Remaining 18 hours: 0.5 mg/min continuous infusion (540 mg total) 1, 2, 3
  • Total first 24 hours: Approximately 1000 mg 3

For cardiac arrest with VF/pulseless VT unresponsive to defibrillation: Use 300 mg IV/IO bolus, with a second 150 mg bolus if the rhythm persists 2

Maintenance Infusion Beyond 24 Hours

  • Continue at 0.5 mg/min (720 mg per 24 hours) for up to 2-3 weeks 3
  • The infusion rate may be increased to achieve effective arrhythmia suppression 3
  • Mean daily doses above 2100 mg are associated with increased risk of hypotension 3

Breakthrough Arrhythmias

If VF or hemodynamically unstable VT recurs during maintenance infusion:

  • Administer supplemental 150 mg bolus mixed in 100 mL D5W over 10 minutes 3
  • This minimizes potential for hypotension 3

Critical Administration Requirements

Concentration and venous access:

  • For concentrations >2 mg/mL: Central venous catheter is mandatory 2, 3
  • For infusions >1 hour: Do not exceed 2 mg/mL concentration unless using a central line 2, 3
  • Concentrations >3 mg/mL are associated with high incidence of peripheral vein phlebitis 3

Equipment requirements:

  • Must use volumetric infusion pump (drop counter sets can underdose by up to 30%) 3
  • Use in-line filter during administration 3
  • Administer in glass or polyolefin bottles containing D5W for infusions exceeding 2 hours 3
  • Do not use evacuated glass containers for admixing 3

Monitoring Parameters

Cardiovascular monitoring:

  • Hypotension occurs in 16% of IV patients 2
  • Bradycardia occurs in 4.9% of IV patients 2
  • Monitor for AV block, heart block, and QT prolongation 1, 2
  • Continuous cardiac monitoring is essential 2

Common pitfall: Do not exceed initial infusion rate of 30 mg/min, as faster rates have resulted in hepatocellular necrosis and acute renal failure leading to death 3

Contraindications

Absolute contraindications without pacemaker availability:

  • Second- or third-degree AV block 2
  • Sick sinus syndrome 2
  • Severe sinus node dysfunction 2

Transition to Oral Therapy

When converting from IV to oral amiodarone:

  • <1 week of IV: 800-1600 mg oral daily 1, 4
  • 1-3 weeks of IV: 600-800 mg oral daily 1, 4
  • >3 weeks of IV: 400 mg oral daily 1
  • Continue oral loading until total of 10 g administered, then reduce to maintenance dose of 200-400 mg daily 1, 4

Drug interaction adjustments during transition:

  • Reduce digoxin dose by 50% immediately (amiodarone doubles digoxin levels) 4
  • Reduce warfarin dose by 30-50% and check INR within 3-5 days 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Infusion Protocol for Life-Threatening Ventricular Arrhythmias

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amiodarone Oral to Intravenous Equivalency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.